PP_1170x120_10-25-21

0.05% (Emulsion Formulation)

Glenmark receives ANDA approval for clobetasol propionate foam

Glenmark receives ANDA approval for clobetasol propionate foam

MUMBAI — Glenmark  Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for clobetasol propionate foam, 0.05% (Emulsion Formulation), a generic version of Olux 1-E Foam, 0.05%, from Mylan. According to IQVIATM sales data for the 12 month period ending July 2019, the Olux-E Foam, 0.05% market achieved

Adheris Health